1. Home
  2. TAP vs ALKS Comparison

TAP vs ALKS Comparison

Compare TAP & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molson Coors Beverage Company Class B

TAP

Molson Coors Beverage Company Class B

HOLD

Current Price

$41.42

Market Cap

8.5B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$47.63

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAP
ALKS
Founded
1873
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.7B
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
TAP
ALKS
Price
$41.42
$47.63
Analyst Decision
Hold
Buy
Analyst Count
17
14
Target Price
$48.94
$43.43
AVG Volume (30 Days)
2.6M
1.4M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
4.53%
N/A
EPS Growth
N/A
N/A
EPS
2.03
N/A
Revenue
$11,723,800,000.00
$1,475,899,000.00
Revenue This Year
$0.85
$24.26
Revenue Next Year
$0.17
$4.47
P/E Ratio
$20.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.04
$25.17
52 Week High
$54.82
$55.67

Technical Indicators

Market Signals
Indicator
TAP
ALKS
Relative Strength Index (RSI) 49.44 40.85
Support Level $40.53 $47.66
Resistance Level $41.76 $51.25
Average True Range (ATR) 0.96 1.41
MACD -0.12 -0.12
Stochastic Oscillator 33.69 9.75

Price Performance

Historical Comparison
TAP
ALKS

About TAP Molson Coors Beverage Company Class B

Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling, and ranks as the second-largest beer maker in both value and volume in the US, Canada, and the United Kingdom. Through licensing agreements, it also brews and distributes beer and nonbeer beverage categories under partner brands from Heineken, Anheuser-Busch InBev, Asahi, Fever-Tree, and Coca-Cola. North America remains its largest market, accounting for nearly 80% of total revenue.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: